This is an educational research reference covering dosing structure, reconstitution math, supplies, and safety context
Monitor and adjust: Track weight, body composition and subjective hunger to titrate dietary intake and training load
Patients receive pre-treatment labs, dosing customized to their age, weight, health status, and therapy goals, injection training, follow-up labs at 4, 8, and 12 weeks, and written documentation
Short-acting drugs include exenatide twice daily, lixisenatide once daily and oral semaglutide once daily, while long-acting drugs include liraglutide, semaglutide, exenatide, albiglutide and dulaglutide all being administered once weekly
Many patients experience weight loss as a secondary benefit, although it's important to note that Ozempic is not licensed for weight management in the UK (a higher dose formulation called Wegovy is specifically licensed for weight management)